This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Journalology/ Peer Review/ Authorship  • Medical Practice  • Medical Ethics  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Statistics and Research Methods  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 144 words of the full text and any section headings.

To the Editor: The Editorial by Drs DeAngelis and Fontanarosa¹ makes valuable proposals on how to prevent medical publications from being turned into marketing tools by pharmaceutical and medical equipment companies. However, an author's declaration of financial dealings with industry is only meaningful if the monetary value received from each company over a preceding period (perhaps the past 2 years) is clearly stated.

Receiving $2000 for conference expenses carries different obligations and suggests a different relationship compared with receiving a $20 000 honorarium. To preserve personal privacy, the amount received could be declared in financial ranges, as is practiced by publicly listed companies when declaring personnel remuneration to shareholders in their annual report.

Increasing transparency in disclosure will clarify the actual financial interaction between authors and industry. This will lessen the chance that journal articles are subtly transformed into sponsored advertisements.

Financial Disclosures: None reported.

Hean T. Ong, MBBS
ongheanteik@gmail.com
H. T. Ong Heart Clinic
Penang, Malaysia

Jin S. Cheah, MBBS
Department of Medicine
National University of Singapore
Kent Ridge, Singapore

1. DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. 2008;299(15):1833-1835. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2008;300(8):903-904.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
and
JAMA. ;299():1833-1835.
FULL TEXT  

RELATED LETTERS

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():900-900.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():900-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():901-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():901-901.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
, , and
JAMA. ;300():901-902.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():902-902.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():902-903.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

JAMA. ;300():903-903.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():904-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():904-904.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
, , and
JAMA. ;300():904-905.
FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():905-906.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications: The Tort Bar and Editorial Oversight of Medical Journals
Hirsch
Mayo Clin Proc. 2009;84:811-821.
FULL TEXT